Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Interpace Biosciences Inc (QX) | IDXG | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.4456 | 07:35:02 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.4456 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.765 - 3.54 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 1.4456 | USD |
Interpace Biosciences Inc (QX) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 6.27M | 4.31M | - | 40.21M | 802k | 0.19 | 7.81 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Interpace Biosciences (QX) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/09/2024 | 15:29 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/12/2024 | 16:01 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 2/06/2024 | 05:33 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/12/2023 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/16/2023 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/08/2023 | 16:14 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/08/2023 | 15:16 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 10/27/2023 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/22/2023 | 15:53 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 9/22/2023 | 15:20 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 8/09/2023 | 14:47 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/09/2023 | 12:27 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IDXG Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.41 | 1.5175 | 1.29 | 1.45 | 5,690 | 0.0356 | 2.52% |
| 1 Month | 1.45 | 1.552 | 1.26 | 1.42 | 4,536 | -0.0044 | -0.30% |
| 3 Months | 1.09 | 2.60 | 1.045 | 1.48 | 6,765 | 0.3556 | 32.62% |
| 6 Months | 1.1375 | 2.60 | 0.78 | 1.28 | 5,734 | 0.3081 | 27.09% |
| 1 Year | 2.99 | 3.54 | 0.765 | 1.44 | 8,283 | -1.54 | -51.65% |
| 3 Years | 8.00 | 10.98 | 0.51 | 4.33 | 7,480 | -6.55 | -81.93% |
| 5 Years | 3.625 | 10.98 | 0.51 | 4.74 | 10,794 | -2.18 | -60.12% |
Interpace Biosciences (QX) Description
| Interpace Biosciences is an emerging leader in enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. |
